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OBJECTIVE — To test the effects of two Mediterranean diet (MedDiet) interventions versus
a low-fat diet on incidence of diabetes.
RESEARCH DESIGN AND METHODS — This was a three-arm randomized trial in
418 nondiabetic subjects aged 55–80 years recruited in one center (PREDIMED-Reus, north-
eastern Spain) of the Prevencio ´n con Dieta Mediterra ´nea [PREDIMED] study, a large nutrition
intervention trial for primary cardiovascular prevention in individuals at high cardiovascular
risk.Participantswererandomlyassignedtoeducationonalow-fatdiet(controlgroup)ortoone
of two MedDiets, supplemented with either free virgin olive oil (1 liter/week) or nuts (30 g/day).
Diets were ad libitum, and no advice on physical activity was given. The main outcome was
diabetes incidence diagnosed by the 2009 American Diabetes Association criteria.
RESULTS — After a median follow-up of 4.0 years, diabetes incidence was 10.1% (95% CI
5.1–15.1), 11.0% (5.9–16.1), and 17.9% (11.4–24.4) in the MedDiet with olive oil group, the
MedDiet with nuts group, and the control group, respectively. Multivariable adjusted hazard
ratios of diabetes were 0.49 (0.25–0.97) and 0.48 (0.24–0.96) in the MedDiet supplemented
with olive oil and nuts groups, respectively, compared with the control group. When the two
MedDiet groups were pooled and compared with the control group, diabetes incidence was
reduced by 52% (27–86). In all study arms, increased adherence to the MedDiet was inversely
associatedwithdiabetesincidence.Diabetesriskreductionoccurredintheabsenceofsigniﬁcant
changes in body weight or physical activity.
CONCLUSIONS — MedDiets without calorie restriction seem to be effective in the preven-
tion of diabetes in subjects at high cardiovascular risk.
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T
he increasing incidence of type 2 di-
abetesthroughouttheworld,closely
linked to westernized dietary pat-
terns,physicalinactivity,andraisingrates
of obesity, is a challenging health prob-
lem. Lifestyle changes are effective mea-
sures to prevent diabetes, and weight loss
is the main predictor of success (1). Five
clinical trials that examined the effects of
reputedly healthy, energy-restricted diets
together with increased physical activity
in individuals with impaired glucose tol-
erance, a prediabetic stage, showed risk
reductions between 30 and 70% (2–6).
The results of these studies provide con-
vincing evidence that lifestyle modiﬁca-
tion reduces the incidence of diabetes
among high-risk individuals. In four of
these studies (2–5), diabetes rates de-
creased in relation to substantial reduc-
tions in body weight, whereas in the
Indian trial (6) lifestyle intervention was
successful despite no weight loss. Obser-
vational studies have also shown that di-
ets rich in vegetables and low in red meat
and whole-fat dairy products are associ-
ated with a decreased risk of diabetes,
whereas dietary patterns rich in red
meats, processed foods, reﬁned grains,
and sweets increase diabetes risk (7).
The traditional Mediterranean diet
(MedDiet), characterized by high con-
sumption of vegetables, legumes, grains,
fruits, nuts, and olive oil, moderate con-
sumption of ﬁsh and wine, and low con-
sumption of red and processed meat and
whole-fat dairy products, is widely recog-
nizedasahealthydietarypattern(8).Two
prospective studies from Southern Eu-
rope suggested a lower incidence of dia-
betes with increasing adherence to the
MedDiet in previously healthy individu-
als (9) or myocardial infarction survivors
(10).Recently,aclinicaltrialshowedthat,
compared with a low-fat diet, a MedDiet
allowed better glycemic control and de-
layedtheneedforantidiabetesdrugtreat-
ment in patients with newly diagnosed
diabetes (11). However, the role of the
MedDiet in the prevention of diabetes has
not been tested in a clinical trial.
We conducted a randomized con-
trolled trial to compare the effect on dia-
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restricted nutritional interventions: a
low-fat diet (control diet), a MedDiet en-
richedwithvirginoliveoil,andaMedDiet
enriched with mixed nuts.
RESEARCH DESIGN AND
METHODS— The Prevencio ´n con
Dieta Mediterra ´nea (PREDIMED) study is
amulticenter,randomized,parallelgroup
primary prevention trial conducted in
Spain to assess the effects of two Med-
Diets,supplementedwitheitherextravir-
gin olive oil or mixed nuts, versus a low-
fat control diet on cardiovascular and
other chronic disease outcomes in indi-
viduals at high cardiovascular risk. Full
details of the PREDIMED protocol have
been published elsewhere (12) and are
available at www.predimed.org and www.
predimed.es. Recruitment took place be-
tween October 2003 and June 2008,
including 7,232 participants randomly as-
signed to the three interventions.
InonlyoneofthePREDIMEDcenters
(PREDIMED-Reus) was a yearly oral glu-
cosetolerancetest(OGTT)innondiabetic
participants part of the protocol. The
present report represents a nested sub-
study with the aim of assessing the effects
of the three interventions on the inci-
dence of diabetes using a yearly OGTT as
a diagnostic tool. The local institutional
review board approved the study proto-
col, and all participants provided written
informed consent.
Candidates for the study were com-
munity-dwelling men aged 55–80 years
and women aged 60–80 years without
prior cardiovascular disease but having at
least three cardiovascular risk factors,
namely smoking, hypertension, dyslipi-
demia,overweight(BMI25kg/m
2),and
family history of premature cardiovascu-
lar disease (55 years in men and 60
years in women). Participants with prev-
alent diabetes were excluded from the
present analysis. Other exclusion crite-
ria were any severe chronic illness, al-
cohol or drug abuse, BMI 40 kg/m
2,
and history of allergy or intolerance to
olive oil or nuts (12).
A behavioral intervention promoting
the MedDiet was implemented, as de-
scribed previously (12). In brief, on the
basis of the initial assessment of individ-
ual scores of adherence using a 14-item
questionnaire, dietitians gave personal-
ized dietary advice to participants ran-
domly assigned to both MedDiets, with
instructionsdirectedtoscaleupthescore,
including,amongothers,1)abundantuse
of olive oil for cooking and dressing, 2)
increased consumption of fruit, vegeta-
bles, legumes, and ﬁsh, 3) reduction in
total meat consumption, recommending
white meat instead of red or processed
meat, 4) preparation of homemade sauce
with tomato, garlic, onion, and spices
with olive oil to dress vegetables, pasta,
rice, and other dishes, 5) avoidance of
butter, cream, fast food, sweets, pastries,
and sugar-sweetened beverages, and 6)i n
alcohol drinkers, moderate consumption
of red wine.
At inclusion and quarterly thereafter,
dietitians administered both individual
interviews and group sessions, separately
for each group. Sessions consisted of in-
formative talks and delivery of written
material with elaborate descriptions of
typicalfoodsforeachdietarypattern,sea-
sonal shopping lists, meal plans, and rec-
ipes. Participants assigned to MedDiet
groups were given free allotments of ei-
ther virgin olive oil (1 liter/week) or
mixed nuts (30 g/day). Participants as-
signed to the low-fat diet received recom-
mendationstoreducealltypesoffat,from
bothanimalandvegetablesources,butno
free foods. Instead, to encourage adher-
ence, at quarterly visits they were given
small gifts, such as oil dispensers, aprons,
shopping bags, or cookbooks. Energy re-
striction was not advised, nor was physi-
cal activity promoted.
At baseline and at each annual visit
we administered 1) a short-questionnaire
about lifestyle variables, medical condi-
tions, and medication use, 2) a 14-item
questionnaire of adherence to the Med-
Diet (12), 3) a 137-item validated food
frequency questionnaire (13), and 4) the
validated Spanish version of the Minne-
sota Leisure-Time Physical Activity ques-
tionnaire (14). Staff involved in collecting
questionnaires and physical measures
were unblinded to intervention group.
Energy and nutrient intakes were calcu-
lated from Spanish food composition ta-
bles as described previously (12). At
yearly visits, weight was recorded, sam-
ples of fasting blood were taken, and an
OGTT was scheduled. Plasma glucose
concentrationswerecentrallyanalyzedby
the glucose-oxidase method. Laboratory
technicians were blinded to intervention
group.
We assessed the proportion of partic-
ipants in each group attaining prespeciﬁc
lifestyle goals on at least 50% of the fol-
low-upvisits.Goalsincluded1)improved
adherence to the MedDiet (10 points in
the14-pointscore),2)ahigh(2)mono-
unsaturated fatty acid (MUFA)-to-
saturated fatty acid (SFA) ratio, 3) high
oliveoilconsumption(20g/1,000kcal/
day), 4) high nut consumption (10
g/1,000kcal/day),5)highdietaryﬁberin-
take (14 g/1,000 kcal/day), 6) substan-
tial weight loss (5% of initial body
weight), and 7) high physical activity
(395 kcal/day, the top tertile). Changes
in weight and physical activity were not
intervention goals but were assessed be-
cause of their well-known association
with diabetes.
The primary outcome was new-onset
diabetes, diagnosed according to Ameri-
can Diabetes Association criteria (15),
namely fasting plasma glucose 7.0
mmol/l or 2-h plasma glucose 11.1
mmol/l after a 75-g oral glucose load,
measured yearly. A second test using the
same criteria was required for conﬁrma-
tion. Case ascertainment was done by the
PREDIMED Clinical Event Committee,
whose members were blinded to inter-
vention group. When diabetes was diag-
nosed,participantsandtheirprimarycare
physicians were informed and no further
OGTTs were scheduled. Every effort was
made to retain participants and to ascer-
tain vital status, including telephone calls
and home visits by PREDIMED investiga-
tors if necessary.
Statistical analysis
Comparisons among groups for qualita-
tive variables were done with the 
2 test.
We ﬁtted Cox regression models to assess
the relative risk of diabetes by allocation
group, estimating hazard ratios and 95%
CIs.Thetimevariablewastheintervalbe-
tween randomization and the date of last
follow-up, death, or diabetes diagnosis,
whichever occurred ﬁrst. Participants
whowerefreeofdiabetesorwhowerelost
during follow-up were censored at the
date of the last visit. The assumption of
proportional hazards was tested using
time-dependent covariates. In all analy-
ses, we ﬁtted a Cox regression model ad-
justed for age and sex. In a subsequent
model, we adjusted additionally for base-
line energy intake, BMI, waist circumfer-
ence, physical activity, smoking status,
fasting serum glucose, use of lipid-
lowering drugs, MedDiet score, and
weight change during the study. The last
modelwasrepeatedaftermergingthetwo
MedDiet groups into a single category.
Multiplicative interaction (effect modiﬁ-
cation) between the intervention (“Medi-
terranean diets,” i.e., the two groups
merged into one category) and age, sex,
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sessed using the likelihood ratio test for
multiplicative product terms introduced
in fully adjusted Cox models. Kaplan-
Meier survival curves were plotted to es-
timatetheprobabilityofremainingfreeof
diabetes during follow-up. Analyses were
based on the intention-to-treat principle.
All P values are two-tailed at the 0.05
level. Statistical analysis were performed
with SPSS (version 17.0; SPSS, Chicago,
IL) software.
RESULTS— Of 1,125 eligible candi-
dates, 870 fulﬁlled the inclusion criteria
and entered the trial. Of these, 452 were
excluded because of a prior diagnosis of
diabetes. A total of 418 nondiabetic vol-
unteers were randomly assigned into the
threegroups(supplementaryFig.1,avail-
able in an online appendix at http://care.
diabetesjournals.org/cgi/content/full/
dc10-1288/DC1). The ﬁrst participant
entered the study in October 2003 and
the last one in June 2008. Most partici-
pants (98.8%) were enrolled for at least 1
year, 88.3% were enrolled for 3 years,
and 19.9% were enrolled for 6 years.
The median follow-up was 4.0 years (in-
terquartilerange,3.0–5.0).Attritionrates
werelowandwerealmostexclusivelydue
to major disease events or death.
Table1showsbaselinecharacteristics
of participants according to intervention
arm. The mean age was 67.3 years, and
58.4% of participants were women. The
groupswerewellbalancedwithrespectto
most relevant variables. However, partic-
ipantsinthecontrolgroupusedfewerlip-
id-lowering drugs and had a lower
MedDiet score than the other two groups.
Participants refused the OGTT on 17% of
the scheduled occasions, and 41 (9.8%)
of them had none performed.
The diets were well tolerated. Up to
3% of participants in each treatment arm
reported difﬁculties in following the pre-
scribed diets, which were solved in all
cases by the dietitians through individual
counsel, negotiation, and small diet ad-
justments. The number of participants in
each group who reported improved
bowel motions (5.2–8.1%) was approxi-
mately twice the number of those who
complainedofnewlydevelopedconstipa-
tion (3.3–3.7%). Supplementary Table 1
(available in an online appendix) shows
the proportion of participants in each
group who attained prespeciﬁed goals
during the trial. The goals of higher
MUFA-to-SFAratios,higherintakesofto-
tal olive oil, nuts, fruit and vegetables, le-
gumes, and ﬁsh, and a MedDiet score
10 were achieved more frequently by
participants allocated to the two MedDi-
ets than by those in the control group,
whereas a small proportion of partici-
pants in each group reached substantial
dietary ﬁber intakes. Only 21% of partic-
ipants in the control group achieved the
goal speciﬁc for this group of total fat in-
take 35% of energy. Weight changes
among the 418 participants at the end of
follow-up were 0.2  4.6 kg for the
olive oil diet group, 0.6  4.2 kg for
thenutdietgroup,and0.64.3kgfor
the low-fat diet group (P  0.74 for the
comparison between groups). Likewise,
physical activity changes were similar in
thethreegroups:17.4336,58.8
297, and 35.8  257 kcal/day, respec-
tively(P0.50).Asshowninsupplemen-
tary Table 1, at the end of the study,
participantssustainedweightloss5%toa
similar extent in the three groups, and a
lower proportion of those in the control
group were in the top tertile of physical ac-
tivity. There were few changes in medica-
Table 1—Characteristics of the study population at baseline
MedDiet with
VOO group
MedDiet with
nuts group
Control diet
group
n 139 145 134
Age (years) 67.4  6.1 66.6  5.8 67.8  6.1
Male sex (%) 40 47 38
Current smoker (%) 11 15 15
Weight (kg) 75.3  10.3 76.1  10.5 76.2  11.3
BMI (kg/m
2) 29.7  3.3 29.6  3.1 30.0  3.3
Waist circumference(cm) 101.1  8.6 100.3  8.5 102.2  9.4
Leisure-time physical activity (kcal/day) 372  280 389  267 338  209
Plasma biomarkers
LDL cholesterol (mmol/l) 3.7  0.9 3.5  0.8 3.7  0.9
HDL cholesterol (mmol/l) 1.5  0.3 1.5  0.4 1.5  0.4
Triglycerides (mmol/l) 1.5  0.6 1.6  0.8 1.6  0.8
Non–HDL cholesterol (mmol/l) 4.3  0.9 4.2  0.9 4.4  1.0
Fasting glucose (mmol/l) 5.5  0.8 5.5  0.9 5.5  0.9
2-h postload glucose (mmol/l)* 7.1  2.6 6.9  2.4 7.4  2.9
Fasting insulin (U/ml)† 5.8  3.6 5.4  3.2 6.2  4.4
HOMA-IR† 1.41  0.87 1.34  0.87 1.60  1.17
Medication use (%)
Lipid-lowering drugs 46.8 47.6 40.3
Antihypertensive medication 82.0 82.1 78.4
Estrogen replacement therapy 2.4 0.0 2.4
Energy, food, and nutrient intake
Total energy (kcal/day) 2,320  579 2,365  570 2,314  580
Carbohydrate (% energy) 41  64 0  64 1  7
Protein (% energy) 16  31 6  21 6  2
Fat (% energy) 41  64 1  64 0  7
MUFA-to-SFA ratio 1.9  0.4 2.0  0.4 1.9  0.5
Total ﬁber (g/day) 23.7  7.6 23.6  8.0 23.0  7.7
Olive oil (g/day) 41.2  17.7 42.0  16.5 40.1  20.4
Nuts (g/day) 13.1  15.0 14.4  15.4 9.3  12.1
Vegetables (g/day) 309  129 310  141 286  117
Fruits (g/day) 298  185 315  164 286  168
Legumes (g/day) 18  7.9 19  9.0 18  8.4
Cereals (g/day) 248  98 245  99 251  105
Red meat and meat products (g/day) 80  44 86  46 84  47
Milk and dairy products (g/day) 355  201 348  183 346  207
Seafood (g/day) 107  42 104  43 99  41
Alcohol (g/day) 8  11 11  14 9  12
Red wine (ml/day) 57  95 75  101 64  89
Score of adherence to the MedDiet 8.4  1.9 8.4  1.9 7.9  1.9
Data are means  SD or %. VOO, virgin olive oil. *Data were available for 263 participants. †Data were
available for 307 participants.
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antihypertensive therapy was initiated by
15.6 and 6.1% of participants and discon-
tinuedby5.4and3.2%,respectively,witha
similar distribution among groups.
During the study, 54 individuals de-
veloped new-onset diabetes. Supplemen-
tary Table 2 (available in an online
appendix) shows that the rate per 1,000
person-years of diabetes incidence was
24.6 (95% CI, 13.5–40.8) for the Med-
Diet with virgin olive oil group, 26.8
(15.3–43.0) for the MedDiet with nuts
group, and 46.6 (30.1–68.5) for the con-
trol group. Cumulative incidence of dia-
betes was 10.1 (5.1–15.1) in the MedDiet
with olive oil group and 11.0 (5.9–16.1)
in the MedDiet with nuts group, whereas
it was 17.9 (11.4–24.4) in the control
group.Figure1showsthatcumulativedi-
abetes-free survival was lower in the con-
trol group compared with both MedDiet
groups. After adjustment for various con-
founders, incident diabetes was reduced
by 51% in the MedDiet with olive oil
group and by 52% in the MedDiet with
nuts group in comparison with the con-
trol group (Table 2). Thus, when the two
MedDiet groups were merged into a sin-
glecategoryinasimilarlyadjustedmodel,
diabetes incidence was reduced by 52%.
In multivariable regression models, sex,
age, baseline obesity, and baseline fasting
glucose were unrelated to outcomes.
Diabetes incidence was lower in par-
ticipants assigned to the two MedDiets
(considered together), who attained 4
of the 7 prespeciﬁed goals or achieved a
MedDiet score 10 (supplementary Fig.
2, available in an online appendix). Thus,
6.3% of participants in the MedDiet
groupsdevelopeddiabetesiftheyattained
4 goals compared with 15.0% of those
who reached 4 goals (P  0.02). Rates
depending on attainment or not of a high
score (10) of adherence to the MedDiet
were 9.4 vs. 20.6% (P  0.07), respec-
tively, in the control group. Changes in
weight or physical activity did not differ
among participants in each intervention
arm developing or not developing diabe-
tes at the end of the study. In the control
group, however, subjects developing dia-
beteshadsustainedameanweightgainof
1.8  3.3 kg, whereas those remaining
diabetes-free had an average weight loss
of 1.1  4.4 kg, a nearly signiﬁcant dif-
ference (P  0.10).
CONCLUSIONS — In this nutrition
intervention study we found that a non–
calorie-restricted traditional MedDiet en-
riched with high-fat foods of vegetable
origindecreasedtheincidenceofdiabetes
in individuals at high cardiovascular risk
after a median follow-up of 4.0 years. Di-
abetes rates were reduced by 51 and 52%
by the consumption of MedDiets supple-
Figure 1—Cumulative diabetes free-survival by group of intervention. Cox regression models
with outcome of diabetes onset and exposure to MedDiet intervention group vs. control diet group,
adjustedbysex,age,baselineenergyintake,BMI,waistcircumference,physicalactivity,smoking
status, fasting serum glucose, use of lipid-lowering drugs, Mediterranean diet score, and weight
change during the study. a, MedDiet and virgin olive oil group; b, MedDiet and nuts group; c,
control diet group.
Table 2—Hazard ratios (95% CI) of diabetes by intervention group
MedDiet with VOO
vs. control diet
MedDiet with nuts vs.
control diet
Both MedDiets vs.
control diet
Crude model 0.53 (0.27–1.09) 0.58 (0.31–1.10) 0.55 (0.32–0.95)
Age- and sex-adjusted model 0.52 (0.27–1.00) 0.55 (0.29–1.00) 0.53 (0.31–0.92)
Multivariate adjusted model* 0.49 (0.25–0.97) 0.48 (0.24–0.96) 0.48 (0.27–0.86)
Sex†
Male 0.48 (0.16–1.46) 0.65 (0.21–2.00) 0.55 (0.21–1.43)
Female 0.47 (0.19–1.17) 0.32 (0.11–0.93) 0.40 (0.18–0.90)
Age†
67 years 0.50 (0.18–1.39) 0.65 (0.26–1.61) 0.58 (0.26–1.31)
67 years 0.26 (0.08–0.83) 0.27 (0.07–0.98) 0.26 (0.09–0.76)
BMI†
30 kg/m
2 0.56 (0.21–1.49) 0.52 (0.19–1.41) 0.54 (0.24–1.22)
30 kg/m
2 0.50 (0.18–1.42) 0.62 (0.22–1.76) 0.56 (0.23–1.43)
Fasting glucose†
6.1 mmol/l 0.44 (0.16–1.25) 0.60 (0.24–1.50) 0.53 (0.23–1.20)
6.1 mmol/l 0.29 (0.09–0.95) 0.39 (0.11–1.37) 0.32 (0.11–0.98)
Cox regression models to assess the relative risk of diabetes by allocation group, estimating the hazard ratios
(95% CI), were performed. Pinteraction (MedDiet 	 sex)  0.496; Pinteraction (MedDiet 	 age)  0.195;
Pinteraction(MedDiet	BMI)0.592;Pinteraction(MedDiet	fastingglucose)0.932.VOO,virginoliveoil.
*Adjusted for sex, age, baseline energy intake, BMI, waist circumference, physical activity, smoking status,
fasting serum glucose, use of lipid-lowering drugs, Mediterranean diet score, and weight changes during the
study. †Adjusted for the same variables as in footnote *, except for the variable of interest.
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nuts, respectively, compared with a con-
trol diet consisting of advice on a low-fat
diet.WhentheresultsofthetwoMedDiet
groups were merged, risk reduction was
52%. These results extend those of prior
studies showing that lifestyle interven-
tions can substantially reduce the inci-
dence of diabetes in individuals at high
risk (2–6). However, in these studies, the
interventions consisted of advice on a cal-
orie-restricted diet plus physical activity
and, except for one study (6), weight loss
was a major driving force in reducing the
incidence of diabetes. Of note, in our
study,diabetesriskreductionoccurredin
theabsenceofsigniﬁcantchangesinbody
weight or physical activity.
Our estimate of the magnitude of the
effect of the MedDiet can be viewed as
conservative because the data were ana-
lyzed by intention to treat, even though
some participants in all treatment arms
might not have been fully compliant with
theintendeddietarymodiﬁcations.Asde-
scribedinotherreportsofthePREDIMED
study(12,16),asizableproportionofpar-
ticipants in the control group, despite be-
ing advised to follow the low-fat diet, did
not substantially reduce total fat intake
(supplementary Table 1), because of a
long-lasting preference for using olive oil
in the kitchen and at the table in Mediter-
ranean cultures. In fact, diabetes risk was
reduced to a similar extent in participants
ofalltreatmentarmswhoreportedhigher
scores of adherence to the MedDiet (sup-
plementary Fig. 2).
Our results are consistent with prior
evidence suggesting a protective effect of
the MedDiet against diabetes (7,9–11).
Characteristically, the MedDiet is a high-
fat,high-unsaturatedfatdietarypattern,a
feature that was maximized in our study
by the free provision of virgin olive oil
(rich in MUFAs) and mixed nuts (rich in
MUFAs and polyunsaturated fatty acids)
to participants in the MedDiet groups. As
suggested by the known associations
among subtypes of dietary fat and diabe-
tesrisk(17),theincreasedunsaturatedfat
load of our MedDiets was probably in-
strumental in achieving diabetes risk
reduction.
The results of a prior PREDIMED
study report (12) support the protective
role of olive oil and nuts against diabetes
risk, as both MedDiets were associated
with improved fasting glucose in diabetic
participants and decreased insulin resis-
tance in those without diabetes after a
3-month follow-up, again in the absence
of weight loss. In the same study (12), a
reduction in circulating inﬂammatory bi-
omarkers was observed in the two Med-
Diet groups. Because chronic low-grade
inﬂammation is a pathogenetic factor in
diabetes, synergy among the anti-
inﬂammatory properties of the MedDiet
and those speciﬁc to virgin olive oil (18)
and nuts (19) might also be relevant to
diabetes risk reduction. Regarding nuts,
reports from large prospective studies
suggest that usual intake relates inversely
to future diabetes risk in women (20) but
not in men (21). No such data are avail-
able for olive oil consumption and risk of
diabetes. However, a former report of the
PREDIMED trial (16) showed that, com-
pared with the control diet, both Med-
Diets, particularly the nut-enriched diet,
had a favorable effect on metabolic syn-
drome status after intervention for 1 year.
The fact that in our study participants in
any treatment arm who were more com-
pliant with the MedDiet had two to three
times lower incidence of diabetes than
those with lesser scores supports a bene-
ﬁcial effect of the whole MedDiet pattern.
There are some limitations to our
study. First, the Mediterranean cohort
studied was older in age and at high risk
for cardiovascular disease. The generali-
zation of our ﬁndings to younger and/or
healthier individuals from other geo-
graphical locations is uncertain. Never-
theless, it is plausible that the beneﬁcial
effectoftheMedDietondiabetesriskmay
be reproduced in other populations, as it
has been shown for all-cause mortality,
cardiovascular disease incidence, and
cancermortalityinU.S.populations(22).
Second, the lifestyle score used in our
study to determine whether changes in
dietary goals related to diabetes incidence
could not reﬂect the totality of dietary
changes, thus making difﬁcult to show
signiﬁcant differences among interven-
tions. Third, some participants did not
undergo an OGTT, thus limiting an even-
tual diagnosis of diabetes to a fasting
bloodglucose7.0mmol/lconﬁrmedby
a second test, which might have falsely
lowered overall incident rates. Finally,
our sample size was relatively small, be-
cause the results are based on fewer than
55 incident cases, and the CIs for our es-
timates are wide. Longer follow-up of the
PREDIMED cohort may eventually pro-
vide stronger evidence of diabetes pre-
vention by the MedDiet.
In summary, the results show that a
non–energy-restricted traditional Med-
Diet high in unsaturated fat can be a use-
ful tool for preventing diabetes. Because
other studies have shown that the beneﬁt
of lifestyle modiﬁcation in reducing dia-
betesriskextendsbeyondthetermination
of active intervention (23–25), education
of the population on the MedDiet might
be a safe public health approach to delay
or prevent development of diabetes as
wellasthatofotherprevalentchronicdis-
eases (22). Further research is needed to
elucidate the mechanisms leading to dia-
betes risk reduction independently of
weight loss.
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